Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Revenues:
Premiums	$ 33,719	$ 30,925	$ 100,734	$ 91,983
Net investment income	632	550	1,639	1,398
Total revenues	102,871	95,428	296,374	275,099
Operating costs:
Cost of products sold	57,045	52,948	162,107	151,019
Health care costs	32,020	29,922	92,472	85,578
Operating expenses	11,288	10,557	33,522	31,185
Goodwill impairment	5,725	0	5,725	0
Restructuring charges	0	1,169	0	1,169
Total operating costs	106,078	94,596	293,826	268,951
Operating income (loss)	(3,207)	832	2,548	6,148
Gain on deconsolidation of subsidiary	483	0	483	0
Interest expense	(784)	(752)	(2,332)	(2,200)
Other income	26	25	83	74
Income (loss) before income tax provision	(3,482)	105	782	4,022
Income tax provision	508	34	1,977	1,059
Net income (loss)	(3,990)	71	(1,195)	2,963
Net loss attributable to noncontrolling interests	15	16	20	7
Net income (loss) attributable to CVS Health	$ (3,975)	$ 87	$ (1,175)	$ 2,970
Net income (loss) per share attributable to CVS Health:
Basic (in dollars per share)	$ (3.13)	$ 0.07	$ (0.93)	$ 2.36
Diluted (in dollars per share)	$ (3.13)	$ 0.07	$ (0.93)	$ 2.35
Weighted average shares outstanding:
Basic (in shares)	1,269	1,259	1,266	1,258
Diluted (in shares)	1,269	1,259	1,266	1,262
Cost, Product and Service [Extensible List]	Products	Products	Products	Products
Products
Revenues:
Revenues	$ 64,590	$ 59,674	$ 182,866	$ 169,610
Services
Revenues:
Revenues	$ 3,930	$ 4,279	$ 11,135	$ 12,108